BUMPUS NAMANDJE received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/19/2025ACC: 0001601830-25-000048
Director
Since Mar 2025
+109.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
109.65K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+36.55K
Price / share
—
Trade value
—
% of position
New position
3/17/2025
0.00→36.55K
Total
Net shares
+36.55K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/17/2025 | A · Award | +36.55K | — | — | New position | 0.00 | 36.55K |
| Total | +36.55K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
73.10K shares
Shares
+73.10K
Strike price
6.84
Held after
73.10K
Exercisable
—
3/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock73.10K shares | 3/17/2025 | A · Award | +73.10K | 6.84 | — | 73.10K |